Member Info for dactions

Eroxon

Sent using the mobile mail app In January I remarked that the then forecast trading news would be seen as good and the sp would soon benefit from the then circa 2.5p level.

Any company or more to the point, Management that can get to the economic point that they did in the face of this pandemic has to be seen as excellent.

In this first quarter of trading they have excelled, the near term target is 10p in my opinion and is a realistic target too.

My only concern is where is the target after that is achieved not whether it’ll be achieved. However, I’m very optimistic that if the current trading growth is maintained (and why shouldn’t it ?), then come the June trading half year, we will achieve 15p.

The current management has all the skill-sets needed, they’re ready to prove themselves and being mostly new, have the energy levels to succeed.

In my opinion, this remains one of the best AIM shares at present which offers the exciting opportunity of sp growth potential and also where management has promised early dividend returns.

I’m pleased with today’s report - and mightily glad that Roy Kelly is now firmly in control.

Surely we have enough knowledge now to let it be used in some way in India for example ?

So Futura receives CE mark a whole month earlier than anticipated allowing the BoD to get on selling the product. This is just the product that can quickly be on sale in the likes of Boots Superdrug etc. These are not tough nuts to crack so I’m expecting share growths to be resumed.

Looking forward to the coming months - good luck all.

gggg21 - posted this link on the other negative & other downbeat which I didn’t want to bring to the top.
https://pittsburgh.cbslocal.com/2021/04/22/upmc-outpatient-trial-mild-early-covid-19/

I appreciate it’s possible that the recipient Megan Maida received a placebo, but in my opinion less likely and it’s the very comment we are hopeful will be proven very soon. A little more patience is all that is required.

GLA

Did anyone get to see the Coro webinar and have any comments as to how it went please ?

That's very insightful Matterhorn - thanks for explaining your thoughts so well.

Oakleaf - Synogold
Thanks for the links - yes they may be easy reporting as some have said - but they provide direct links to other pages including the New York one to Synairgen's own webpages, and on that point, we now always see Synairgen's name somewhere in the news comments.

As a shareholder, it's certainly a little uncomfortable right now - when probably most of us are thinking "why didn't I sell up or at least top-slice ?". I had originally forecast mid to late February for the positive news I'm still convinced will be forthcoming - but that was based on trials starting 10 weeks earlier than they did.

So, in a nutshell and nailing my colours to the mast - add 10 weeks - news imminent (oops we're have I heard 'imminent' before ??) within the next 3 weeks.

GLA

....and the point is Hedgefundking ?
You keep coming out with quotes with no source noted - they may well be true & positive but I'd like to know who said them ... and why do you keep starting new threads one after the other ?

I replied this morning but my post was taken down ?!?

Roly - thanks for info - you can register for the webinar easily via their website: falanxcyber.com
I recently watched a podcast on passwords which I found useful and can recommend it - no hard sell or other commitment - just useful to quickly keep up with IT. This is the first time in years that I've seen their web being used to project their business.

Hopefully in the months ahead, we'll come to see this as a pivotal point for the Company and us as shareholders - again hopefully, clawing back the presently sorry state of the share price.

I decided to add further shares this morning on the back, as I see it, of this business marketing change. GLA

Thanks Roly12 - I listened in to a Falanx podcast on password protection which was well done - as a Company, it looks like they're upping their game at last.

https://falanxcyber.com/upcoming-webinar-how-can-organisations-protect-against-state-sponsored-cyberattacks/

I am considering adding NoelShempsky.

In fact had intended to do so on Friday - but got sidetracked and added FUM instead where I am hoping for a lift in their SP once CE mark news is officially confirmed.

But regarding Falanx, I noted some recent positive press coverage on Cyber security shares (Falanx wasn't mentioned - just the industry) and that Businesses are paying for many more services because of the Covid pandemic. I would like to think that even Falanx will benefit and given how 'bombed-out' its shares are, could this, at last, see a genuine turn for the better for this Company ?

Blessed - it's not nice to see someone 'crowing' - there are better ways to help fellow investors.

Doc - equally, sometimes I think you are to quick to see offence.

"Who cares Mara what you think. A D 2021-2021"

I like it Tritobeobjective :-)

Maragon - thanks for details this time - sorry if I was showing irritability with your one-liners. It's true that there have been peaks and troughs with WBI as they switched emphasis from one African country to another - for a time under the previous Board of Miles Pelham they did seem to be getting it right but were over-extending themselves financially. If I'd been more aware I should have too taken advantage of the ups & downs instead of watching it drift.

My excuse is I believed the then management and without regular updates that was me being naive. Now it is a different story, focus has changed completely under the new Management, different countries, different business, different financing. Ok, I know that simplifies it too much but in essence the main focus on Gabon in particular, on timber trading and being given regular updates means we can now judge for ourselves success or failure.

We're in a growth stage now and to achieve this in the face of a global pandemic is remarkably good and effective management.

Today's firming of the sp after recent profit-taking augers well - hopefully Maragon you'll be back with us for the next run up.

I think it's fair to say Aquasulis01 that the promise of a 'growth' stock is one of steady but positive growth - not something one can say has happened here for several years now - originally yes - but now.

The share is languishing I think we all agree - it seems the BoD are rudderless !

It's my view that confirmation of CE mark for Eroxon will be the next trigger to jump the share price to nearer 80p - but it will only sustain that level with commercialization news of one kind or another.

Calm it please - it's not the playground.

Thanks Hedgefundking - you were quite right to promote the significance of Prof. Arthur Burnett and the merits of his comments. I'd glossed over the RNS previously. And more to the point he knows that it is MED3000 (ie. without th GTN active ingredient) that the trial is referring to and is still enthusiastic.

He is rated very highly in ED specialism and read in his profile that:
"Dr. Burnett is recognized for being a world-authority in the science and medicine of erectile dysfunction. He contributed original discoveries of the nitric oxide biochemical mechanisms in erectile tissue, which paved the way for the clinical development of oral medications to treat erectile dysfunction such as Viagra. He has also pioneered work to develop therapies to protect penile nerve function required for improved erectile function recovery after radical prostatectomy"

The key for us as shareholders is news of commercialisation partner(s) - that will drive the price significantly in my opinion.

Your one-liners are always insightful Maragon - but what did you sell at ?